Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antimicrobial Stewardship | 4 | 2023 | 84 | 1.800 |
Why?
|
| Iatrogenic Disease | 2 | 2021 | 130 | 1.290 |
Why?
|
| Bacteriuria | 2 | 2024 | 82 | 1.230 |
Why?
|
| Anti-Bacterial Agents | 11 | 2024 | 2391 | 1.200 |
Why?
|
| Drug Utilization | 2 | 2020 | 157 | 1.140 |
Why?
|
| Endocarditis, Bacterial | 2 | 2017 | 129 | 1.030 |
Why?
|
| Anti-Infective Agents | 3 | 2023 | 266 | 1.030 |
Why?
|
| Skin Diseases | 2 | 2017 | 122 | 0.990 |
Why?
|
| Personal Protective Equipment | 2 | 2022 | 54 | 0.950 |
Why?
|
| Prosthesis-Related Infections | 2 | 2016 | 176 | 0.900 |
Why?
|
| Eosinophilia | 2 | 2014 | 102 | 0.860 |
Why?
|
| Herpes Genitalis | 1 | 2021 | 11 | 0.780 |
Why?
|
| Communicable Diseases | 1 | 2023 | 163 | 0.750 |
Why?
|
| HIV Infections | 3 | 2021 | 1859 | 0.750 |
Why?
|
| Staphylococcal Infections | 3 | 2016 | 552 | 0.720 |
Why?
|
| Sepsis | 2 | 2017 | 478 | 0.720 |
Why?
|
| Sexual and Gender Minorities | 1 | 2021 | 59 | 0.720 |
Why?
|
| Staphylococcus aureus | 2 | 2014 | 457 | 0.690 |
Why?
|
| Urine | 1 | 2020 | 88 | 0.690 |
Why?
|
| Physicians | 3 | 2024 | 582 | 0.670 |
Why?
|
| Mandatory Programs | 1 | 2018 | 5 | 0.640 |
Why?
|
| Candidiasis | 2 | 2016 | 129 | 0.620 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 102 | 0.620 |
Why?
|
| Blood Culture | 2 | 2021 | 29 | 0.600 |
Why?
|
| Urinary Tract Infections | 2 | 2020 | 289 | 0.600 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2020 | 169 | 0.590 |
Why?
|
| Vibrio vulnificus | 1 | 2017 | 4 | 0.580 |
Why?
|
| Vibrio Infections | 1 | 2017 | 16 | 0.580 |
Why?
|
| Mycobacterium abscessus | 1 | 2017 | 11 | 0.580 |
Why?
|
| Quality Improvement | 2 | 2022 | 621 | 0.570 |
Why?
|
| Blood Sedimentation | 1 | 2017 | 28 | 0.570 |
Why?
|
| Infection Control | 2 | 2016 | 161 | 0.570 |
Why?
|
| Nocardia Infections | 1 | 2017 | 15 | 0.560 |
Why?
|
| Heart Valve Prosthesis | 2 | 2017 | 293 | 0.560 |
Why?
|
| Inpatients | 1 | 2021 | 490 | 0.550 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2016 | 35 | 0.550 |
Why?
|
| Methyltransferases | 1 | 2017 | 71 | 0.550 |
Why?
|
| Wound Infection | 1 | 2017 | 51 | 0.550 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2017 | 28 | 0.550 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2017 | 59 | 0.550 |
Why?
|
| Leukocyte Count | 1 | 2017 | 245 | 0.550 |
Why?
|
| Opportunistic Infections | 1 | 2017 | 78 | 0.540 |
Why?
|
| Quality Indicators, Health Care | 1 | 2018 | 214 | 0.540 |
Why?
|
| Peritonitis | 1 | 2016 | 76 | 0.540 |
Why?
|
| Specimen Handling | 1 | 2017 | 137 | 0.530 |
Why?
|
| Case Management | 1 | 2016 | 22 | 0.530 |
Why?
|
| Brain Abscess | 1 | 2017 | 57 | 0.530 |
Why?
|
| Professional Competence | 1 | 2017 | 96 | 0.530 |
Why?
|
| Health Personnel | 1 | 2021 | 500 | 0.520 |
Why?
|
| Mucormycosis | 1 | 2016 | 26 | 0.510 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2016 | 79 | 0.510 |
Why?
|
| Lymphocytes | 1 | 2017 | 404 | 0.490 |
Why?
|
| Endocarditis | 1 | 2016 | 103 | 0.490 |
Why?
|
| Mycoses | 1 | 2016 | 116 | 0.490 |
Why?
|
| Immunocompromised Host | 4 | 2019 | 300 | 0.480 |
Why?
|
| Neutrophils | 1 | 2017 | 373 | 0.480 |
Why?
|
| Abscess | 1 | 2016 | 138 | 0.470 |
Why?
|
| Joint Prosthesis | 1 | 2014 | 12 | 0.470 |
Why?
|
| Diabetic Foot | 1 | 2017 | 156 | 0.470 |
Why?
|
| Arthroplasty | 1 | 2014 | 15 | 0.470 |
Why?
|
| Osteomyelitis | 1 | 2017 | 204 | 0.460 |
Why?
|
| Drainage | 1 | 2016 | 254 | 0.460 |
Why?
|
| Bacteremia | 2 | 2021 | 405 | 0.450 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 263 | 0.450 |
Why?
|
| Education, Medical | 1 | 2016 | 285 | 0.410 |
Why?
|
| Humans | 33 | 2024 | 122423 | 0.410 |
Why?
|
| Texas | 5 | 2024 | 3513 | 0.400 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 635 | 0.390 |
Why?
|
| Catheter-Related Infections | 1 | 2012 | 129 | 0.370 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 814 | 0.360 |
Why?
|
| Substance Abuse, Intravenous | 2 | 2017 | 39 | 0.280 |
Why?
|
| Male | 14 | 2021 | 59600 | 0.270 |
Why?
|
| Fatal Outcome | 2 | 2017 | 356 | 0.260 |
Why?
|
| Postoperative Complications | 2 | 2016 | 2998 | 0.260 |
Why?
|
| Tertiary Care Centers | 2 | 2017 | 236 | 0.230 |
Why?
|
| Antifungal Agents | 2 | 2016 | 293 | 0.220 |
Why?
|
| Urinary Catheterization | 2 | 2013 | 78 | 0.210 |
Why?
|
| Benchmarking | 1 | 2023 | 131 | 0.210 |
Why?
|
| Interdisciplinary Studies | 1 | 2022 | 5 | 0.200 |
Why?
|
| Hospitals | 2 | 2022 | 397 | 0.200 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2016 | 220 | 0.200 |
Why?
|
| Homosexuality, Male | 1 | 2021 | 61 | 0.190 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 1874 | 0.190 |
Why?
|
| Aged | 5 | 2024 | 18781 | 0.190 |
Why?
|
| Logistic Models | 2 | 2018 | 1768 | 0.190 |
Why?
|
| Sexual Partners | 1 | 2021 | 85 | 0.190 |
Why?
|
| Documentation | 1 | 2022 | 115 | 0.190 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2021 | 23 | 0.190 |
Why?
|
| Attitude | 1 | 2021 | 118 | 0.180 |
Why?
|
| Echocardiography | 2 | 2017 | 1067 | 0.180 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3306 | 0.180 |
Why?
|
| Masks | 1 | 2021 | 39 | 0.180 |
Why?
|
| Middle Aged | 6 | 2017 | 25591 | 0.180 |
Why?
|
| Disclosure | 1 | 2021 | 153 | 0.180 |
Why?
|
| Catholicism | 1 | 2020 | 5 | 0.180 |
Why?
|
| Hospitals, Religious | 1 | 2020 | 5 | 0.180 |
Why?
|
| Intensive Care Units | 1 | 2023 | 475 | 0.170 |
Why?
|
| Sexual Behavior | 1 | 2021 | 234 | 0.170 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 261 | 0.160 |
Why?
|
| Fungi | 1 | 2019 | 69 | 0.160 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2017 | 116 | 0.150 |
Why?
|
| Cyclonic Storms | 1 | 2019 | 76 | 0.150 |
Why?
|
| Disasters | 1 | 2019 | 99 | 0.150 |
Why?
|
| Sulfadoxine | 1 | 2017 | 2 | 0.140 |
Why?
|
| Trimethoprim | 1 | 2017 | 4 | 0.140 |
Why?
|
| Device Removal | 2 | 2016 | 223 | 0.140 |
Why?
|
| Environmental Exposure | 1 | 2019 | 217 | 0.140 |
Why?
|
| beta-Glucans | 1 | 2016 | 20 | 0.140 |
Why?
|
| Program Evaluation | 1 | 2018 | 440 | 0.140 |
Why?
|
| Proteoglycans | 1 | 2016 | 93 | 0.140 |
Why?
|
| Skin Diseases, Infectious | 1 | 2016 | 24 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 604 | 0.130 |
Why?
|
| Fungemia | 1 | 2016 | 22 | 0.130 |
Why?
|
| Aspergillosis | 1 | 2016 | 42 | 0.130 |
Why?
|
| Pneumonia, Bacterial | 1 | 2017 | 77 | 0.130 |
Why?
|
| Candida albicans | 1 | 2016 | 76 | 0.130 |
Why?
|
| Histoplasmosis | 1 | 2016 | 45 | 0.130 |
Why?
|
| Dyspnea | 1 | 2017 | 149 | 0.130 |
Why?
|
| Microbiological Techniques | 1 | 2016 | 33 | 0.130 |
Why?
|
| Drug Combinations | 1 | 2017 | 263 | 0.130 |
Why?
|
| Immunocompetence | 1 | 2016 | 33 | 0.130 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 115 | 0.130 |
Why?
|
| Multiple Organ Failure | 1 | 2017 | 140 | 0.130 |
Why?
|
| Amphotericin B | 1 | 2016 | 90 | 0.130 |
Why?
|
| Students, Pharmacy | 1 | 2016 | 63 | 0.130 |
Why?
|
| Soft Tissue Infections | 1 | 2016 | 83 | 0.130 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2016 | 118 | 0.130 |
Why?
|
| Adult | 4 | 2023 | 28746 | 0.130 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 297 | 0.120 |
Why?
|
| Community-Acquired Infections | 1 | 2017 | 240 | 0.120 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2017 | 155 | 0.120 |
Why?
|
| Triazoles | 1 | 2016 | 137 | 0.120 |
Why?
|
| Leg | 1 | 2016 | 154 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2016 | 298 | 0.120 |
Why?
|
| Skin | 1 | 2017 | 506 | 0.120 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2014 | 230 | 0.110 |
Why?
|
| Defibrillators, Implantable | 1 | 2016 | 191 | 0.110 |
Why?
|
| Exanthema | 1 | 2014 | 68 | 0.110 |
Why?
|
| Female | 7 | 2018 | 64961 | 0.110 |
Why?
|
| Asymptomatic Infections | 1 | 2013 | 33 | 0.110 |
Why?
|
| Length of Stay | 1 | 2018 | 1272 | 0.110 |
Why?
|
| Viral Load | 1 | 2014 | 384 | 0.100 |
Why?
|
| Students, Medical | 1 | 2016 | 357 | 0.100 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2011 | 23 | 0.100 |
Why?
|
| Biliary Tract Diseases | 1 | 2011 | 35 | 0.100 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2012 | 148 | 0.090 |
Why?
|
| Zygomycosis | 1 | 2011 | 2 | 0.090 |
Why?
|
| Heroin Dependence | 1 | 2011 | 56 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2794 | 0.090 |
Why?
|
| Spinal Cord Injuries | 1 | 2013 | 311 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2021 | 15879 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 2035 | 0.080 |
Why?
|
| Risk Factors | 2 | 2013 | 9871 | 0.080 |
Why?
|
| Hepatitis E | 1 | 2008 | 5 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2016 | 5974 | 0.080 |
Why?
|
| Biomarkers | 1 | 2017 | 2942 | 0.070 |
Why?
|
| Prevalence | 1 | 2014 | 2371 | 0.070 |
Why?
|
| Prognosis | 1 | 2017 | 4492 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 446 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 1099 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2014 | 3231 | 0.070 |
Why?
|
| Inflammation | 1 | 2014 | 1398 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 3613 | 0.070 |
Why?
|
| Neoplasms | 1 | 2021 | 2752 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 3456 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2014 | 4649 | 0.060 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2008 | 441 | 0.060 |
Why?
|
| United States | 1 | 2018 | 10478 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2011 | 1033 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6303 | 0.050 |
Why?
|
| Emergencies | 1 | 2022 | 175 | 0.050 |
Why?
|
| Public Health | 1 | 2022 | 253 | 0.040 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 169 | 0.040 |
Why?
|
| Invasive Fungal Infections | 1 | 2019 | 13 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2022 | 268 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 607 | 0.040 |
Why?
|
| Macrolides | 1 | 2017 | 28 | 0.040 |
Why?
|
| beta-Lactams | 1 | 2017 | 51 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2023 | 694 | 0.030 |
Why?
|
| Fluoroquinolones | 1 | 2017 | 98 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2017 | 335 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2016 | 143 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 1146 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 1025 | 0.030 |
Why?
|
| Calcinosis | 1 | 2011 | 167 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 3306 | 0.020 |
Why?
|
| Hepatitis E virus | 1 | 2008 | 4 | 0.020 |
Why?
|
| Syndrome | 1 | 2011 | 1122 | 0.020 |
Why?
|
| Hormones | 1 | 2008 | 189 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2013 | 12036 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2011 | 945 | 0.020 |
Why?
|
| Young Adult | 1 | 2011 | 8805 | 0.010 |
Why?
|
| Pregnancy | 1 | 2008 | 7102 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 33897 | 0.000 |
Why?
|